Role of ALDH5A1 in methadone treatment

Marta Torrens; Francina Fonseca

doi:10.2217/pgs.14.13

Role of ALDH5A1 in methadone treatment

Department of Psychiatry and Legal Medicine

Research output: Contribution to journal › Review article › Research › peer-review

Original language	English
Pages (from-to)	573-576
Journal	Pharmacogenomics
Volume	15
Issue number	5
DOIs	https://doi.org/10.2217/pgs.14.13
Publication status	Published - 1 Jan 2014

Keywords

ALDH5A1 gene
GHB
methadone maintenance treatment
MMT
opioid dependence
pharmacogenetics
γ-aminobutyric acid
γ-hydroxybutyric acid

Access to Document

10.2217/pgs.14.13

Cite this

Torrens, M., & Fonseca, F. (2014). Role of ALDH5A1 in methadone treatment. Pharmacogenomics, 15(5), 573-576. https://doi.org/10.2217/pgs.14.13

@article{c76202c2525e44a1ba287bdab1eca333,

title = "Role of ALDH5A1 in methadone treatment",

keywords = "ALDH5A1 gene, GHB, methadone maintenance treatment, MMT, opioid dependence, pharmacogenetics, γ-aminobutyric acid, γ-hydroxybutyric acid",

author = "Marta Torrens and Francina Fonseca",

year = "2014",

month = jan,

day = "1",

doi = "10.2217/pgs.14.13",

language = "English",

volume = "15",

pages = "573--576",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "5",

}

TY - JOUR

T1 - Role of ALDH5A1 in methadone treatment

AU - Torrens, Marta

AU - Fonseca, Francina

PY - 2014/1/1

Y1 - 2014/1/1

KW - ALDH5A1 gene

KW - GHB

KW - methadone maintenance treatment

KW - MMT

KW - opioid dependence

KW - pharmacogenetics

KW - γ-aminobutyric acid

KW - γ-hydroxybutyric acid

U2 - 10.2217/pgs.14.13

DO - 10.2217/pgs.14.13

M3 - Review article

VL - 15

SP - 573

EP - 576

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 5

ER -